Organic electroluminescent materials and devices

US11239434B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11239434-B2
Application numberUS-201916243655-A
CountryUS
Kind codeB2
Filing dateJan 9, 2019
Priority dateFeb 9, 2018
Publication dateFeb 1, 2022
Grant dateFeb 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A compound including a first ligand L A of Formula I is disclosed.

First claim

Opening claim text (preview).

We claim: 1. A compound comprising: a first ligand L A of Formula I wherein, Ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 1 , Z 2 , and Z 3 are each independently selected from the group comprising C and N; Y is selected from the group consisting of O, S, Se, NR 3 , CRR′, SiRR′, GeRR′, and a single bond; Y is not CRR′ when Z 1 , Z 2 , and Z 3 are C; if Y is a single bond, then Z 3 is C and Ring A is not pyridine or if Y is a single bond and Ring A is pyridine, then at least one of Z 1 , Z 2 , or Z 3 is N; a metal M forms a direct bond to Ring A or Ring B; M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, and Au; R A and R B each independently represents mono to a maximum possible number of substitutions, or no substitution; R A , R B , R 1 , R 2 , R 3 , R, and R′ are each independently a hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; one of R A or R B is a 5-membered or 6-membered aromatic ring that is bonded to M; the ligand L A is optionally linked with other ligands to form a ligand having a denticity of tridentate to a maximum possible denticity to which M can coordinate; any two substituents may be joined or fused together to form a ring, provided that R 1 and R 2 are not joined to form a 6-membered aromatic ring when Y is a single bond; and M is optionally coordinated to other ligands. 2. The compound of claim 1 , wherein R A , R B , R 1 , R 2 , R 3 , R, and R′ are each independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein M is selected from the group consisting of Ir and Pt. 4. The compound of claim 1 , wherein Y is a single bond or selected from the group consisting of O, S, and NR 3 . 5. The compound of claim 1 , wherein one of R A or R B comprises a benzene ring, that is bonded to M. 6. The compound of claim 1 , wherein one of R A or R B comprises a pyridine ring, that is bonded to M. 7. The compound of claim 1 , wherein one of Z 1 , Z 2 , or Z 3 is N and forms a dative bond to M, and the remaining two of Z 1 , Z 2 , and Z 3 are C. 8. The compound of claim 1 , wherein Ring A contains an N atom that forms a dative bond to M. 9. The compound of claim 1 , wherein Ring A is a 5-membered aromatic ring or a 6-membered aromatic ring. 10. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of: wherein, R C represents mono to a maximum possible number of substitutions, or no substitution; and R C and R 4 are each independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 11. The compound of claim 1 , wherein L A is selected from the group consisting of L A1 through L A294 having structures of Formula I wherein R 1 , R 2 , R 5 , R 6 , and R 7 are defined as follows: Ligand R 1 R 2 R 7 R 6 R 5 L A1 H H H H H L A2 R B1 H H H H L A3 R B1 R B1 H H H L A4 R B1 R B1 R B1 H H L A5 R B1 H R B1 H H L A6 H H R B1 H H L A7 H H H R B1 R B1 L A8 R B1 H H R B1 R B1 L A9 R B1 R B1 H R B1 R B1 L A10 R B1 R B1 R B1 R B1 R B1 L A11 R B1 H R B1 R B1 R B1 L A12 H H R B1 R B1 R B1 L A13 H H H R B44 R B44 L A14 R B1 H H R B44 R B44 L A15 R B1 R B1 H

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11239434B2 cover?
A compound including a first ligand L A of Formula I is disclosed.
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C09K11/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).